09.07.2024 | Tracker
Top 50 Pharma Tracker: eHCPs eager for updated COVID-19 vaccines following FDA decision
The Top 50 Pharmaceutical Companies mentioned by eHCPs on X
June Rank | May Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
---|---|---|---|---|---|
1 | 1 | Pfizer | 3,628 | 406 | 8 |
2 | 3 | Moderna | 2,011 | 198 | 13 |
3 | 4 | Johnson & Johnson | 1,030 | 419 | 6 |
4 | 2 | AstraZeneca | 574 | 249 | 11 |
5 | 6 | GSK | 549 | 132 | 9 |
6 | 17 | AbbVie | 478 | 425 | 20 |
7 | 12 | Gilead Sciences | 381 | 139 | 4 |
8 | 11 | Novavax | 362 | 64 | 14 |
9 | 5 | Novo Nordisk | 338 | 184 | 22 |
10 | 8 | Bayer | 264 | 94 | 8 |
11 | 15 | Lilly | 241 | 139 | 2 |
12 | 9 | Roche | 238 | 55 | 13 |
13 | 7 | Abbott | 221 | 187 | 10 |
14 | 10 | Sanofi | 211 | 106 | 17 |
15 | 18 | Takeda | 195 | 188 | 0 |
16 | 19 | Merck & Co | 188 | 80 | 1 |
17 | 14 | Novartis | 161 | 106 | 10 |
18 | 16 | Otsuka | 122 | 15 | 0 |
19 | 29 | Boehringer Ingelheim | 111 | 68 | 0 |
20 | 20 | BMS | 99 | 82 | 2 |
21 | 21 | Amgen | 85 | 55 | 1 |
22 | 26 | Organon | 69 | 9 | 0 |
23 | 24 | Fresenius | 51 | 28 | 2 |
24 | 27 | UCB | 43 | 39 | 9 |
25 | 30 | Daiichi Sankyo | 41 | 27 | 2 |
26 | 34 | Merck KGaA | 40 | 36 | 6 |
26 | 41 | Chugai | 40 | 3 | 3 |
28 | #N/A | STADA Arneimittel | 39 | 8 | 0 |
29 | 22 | Regeneron | 36 | 18 | 1 |
30 | 39 | Vertex | 32 | 27 | 2 |
31 | 31 | Astellas | 30 | 20 | 1 |
32 | 35 | Teva | 28 | 24 | 2 |
32 | 38 | Jazz Pharmaceuticals | 28 | 25 | 3 |
34 | 44 | Incyte | 25 | 22 | 1 |
35 | 36 | Viatris | 24 | 1 | 0 |
36 | 28 | Biogen | 21 | 9 | 0 |
36 | 33 | Eisai | 21 | 15 | 0 |
36 | 37 | Bausch | 21 | 3 | 0 |
39 | 40 | CSL | 15 | 12 | 2 |
40 | 32 | Ipsen | 13 | 10 | 2 |
41 | 45 | Sun | 12 | 9 | 0 |
42 | 43 | Grifols | 10 | 1 | 0 |
43 | 23 | Servier | 8 | 5 | 0 |
43 | 25 | Menarini | 8 | 6 | 0 |
45 | #N/A | Dr. Reddy's Labratories | 6 | 1 | 0 |
46 | 50 | Jiangsu Hengrui | 4 | 0 | 0 |
50 | 50 | Shanghai | 0 | 0 | 0 |
50 | 50 | Sino | 0 | 0 | 0 |
50 | #N/A | Yunnan Baiyao Group | 0 | 0 | 0 |
50 | #N/A | Mitsubishi Chemical Group | 0 | 0 | 0 |
June’s insights from eHCPs mentioning the Top 50 Pharmaceutical Companies
The five most mentioned pharmaceutical companies by eHCPs on X in June 2024 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and GSK.
CREATION.co identified 10,430 eHCP mentions of pharmaceutical companies in June 2024, decreasing by 4.4% over the previous month.
On 06 June, eHCPs took to X to discuss the FDA decision to update the formula for vaccine manufacturers for new COVID-19 vaccines. Novavax responded with a message that they are “ready to help”. eHCPs have historically been very positive towards the data that Novavax’s vaccines have produced, and this trend continued in June.
Great! I'll be looking for #Novavax booster this fall!
— Judy Stone (@DrJudyStone) June 6, 2024
Following this, on 15 June eHCPs shared a positive response to Novavax’s intentions to have vaccine doses ready by mid-July. Family doctor Noha Aboelata expressed how she “loves” Novavax’s decision to pre-fill the syringes for doctors.
Sooner than anticipated: "Novavax intends to have doses in the U.S. for distribution by mid-July."
Also love that they're planning pre-filled syringes. 🤗https://t.co/du9hXN3cvm pic.twitter.com/YuY9XhlXW6
— Noha Aboelata, MD (@NohaAboelataMD) June 15, 2024
Shared by 31 eHCPs
On 25 June, eight eHCPs shared a post by the American Society of Echocardiography regarding the latest academic poster for echocardiographic imaging. The poster was developed in collaboration with BMS.
We are pleased to share a new #HCM poster with you all, developed with support from @bmsnews!
Use this link to download the poster, "A Practical Approach to Echocardiographic Imaging in Patients with Hypertrophic Cardiomyopathy." https://t.co/UnQKH6uYw2 pic.twitter.com/5ZKyjgYDQq
— American Society of Echocardiography (@ASE360) June 25, 2024
Shared by 8 eHCPs
The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:
- An academic poster developed by American Society of Echocardiography in collaboration with BMS around Hypertrophic Cardiomyopathy imaging.
- A Novavax press release discussing the application for FDA approval of a new COVID-19 vaccine.
- An FDA article discussing updates to COVID-19 vaccines for manufacturers.
——
Find out how the conversation is changing in other Top 50 Trackers and new analysis of the online HCP conversation in a variety of topics.
You can also receive these updates and more straight to your inbox by signing up to CREATION.co’s monthly eJournal.
Methodology notes:
- In June 2024, CREATION Pinpoint® identified 10,430 posts on X (Twitter) from 4,417 individual eHCPs mentioning a Top 50 Pharmaceutical company (based on revenue).
- Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 – 30 June 2024.
- Unless otherwise specified, mentions of a company are not limited to its X account(s).
- In some cases, a post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Johnson & Johnson Innovative Medicine (previously Janssen). In June 2024, 50 of these posts mentioned Johnson & Johnson Innovative Medicine or Janssen.